Related Experiment Video
Updated: Apr 15, 2026
Chronic Constriction of the Sciatic Nerve and Pain Hypersensitivity Testing in Rats
Published on: March 13, 2012
Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal
Elizabeth Gerard1, Robert N Spengler, Adela C Bonoiu
1Department of Pathology and Anatomical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA NanoAxis, LLC, Clarence, NY, USA Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, NY, USA Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University at Buffalo, The State University of New York, Buffalo, NY, USA Department of Anesthesiology, University at Buffalo, The State University of New York, Buffalo, NY, USA Veterans Administration Western New York Healthcare System Departments of Chemistry and Microbiology and Immunology, University at Buffalo, The State University of New York, Buffalo, NY, USA Program for Neuroscience, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Targeting tumor necrosis factor-alpha (TNF) in the hippocampus with gold nanorod-delivered siRNA effectively reduced neuropathic pain in rats. This approach offers a promising new strategy for treating chronic pain conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Biotechnology
Background:
- Neuropathic pain, resulting from nerve injury, has limited treatment options.
- Pro-inflammatory tumor necrosis factor-alpha (TNF) is a key mediator in neuropathic pain development.
- Previous studies showed TNF inhibition outside the brain offers only transient pain relief.
Purpose of the Study:
- To investigate the efficacy of blocking TNF specifically within the hippocampus for treating neuropathic pain.
- To determine if nanoparticle-delivered siRNA targeting TNF mRNA in the hippocampus can reduce pain behavior.
Main Methods:
- Small inhibitory RNA (siRNA) targeting TNF mRNA was complexed with gold nanorods (GNR-TNF siRNA).
- GNR-TNF siRNA was injected into the hippocampus of rats with chronic constriction injury (CCI)-induced neuropathic pain.
- Pain behaviors (thermal hyperalgesia, mechanical allodynia) and hippocampal TNF levels were measured.
Main Results:
- Hippocampal TNF nanoplex injection significantly decreased thermal hyperalgesia in CCI rats.
- Mechanical allodynia was transiently relieved following treatment.
- TNF levels in hippocampal tissue were reduced post-injection.
Conclusions:
- Targeting TNF within the hippocampus using nanoparticle-protected siRNA is effective in alleviating neuropathic pain-like behaviors.
- This study provides evidence for a novel therapeutic strategy for neuropathic pain by targeting brain-based TNF.
- Hippocampal TNF plays a crucial role in modulating pain perception.
More Related Videos
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
05:38Author Spotlight: Utilizing Infraorbital Nerve Ligation in Mice for Investigating Trigeminal Neuropathic Pain and Treatment Strategies
Published on: March 8, 2024